Scinai Immunotherapeutics Ltd.
Price Action
Technical Summary
DOWNTRENDScinai Immunotherapeutics Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 2), showing significant lag compared to the market leaders. Earnings growth of 3201% provides fundamental context to the price action. Investors should exercise caution due to high volatility (121% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.35 | -24.35% | BELOW |
| 50 SMA | $0.47 | -44.33% | BELOW |
| 100 SMA | $0.60 | -55.97% | BELOW |
| 150 SMA | $0.70 | -62.70% | BELOW |
| 200 SMA | $0.86 | -69.58% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SCNI in an uptrend right now?
SCNI has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is SCNI overbought or oversold?
SCNI's RSI (14) is 27. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.
Is SCNI outperforming the market?
SCNI has a Relative Strength (RS) Rating of 2 out of 99. SCNI is currently lagging the broader market.
Where is SCNI in its 52-week range?
SCNI is trading at $0.26, which is 8% of its 52-week high ($3.48) and 0% above its 52-week low ($0.25).
How volatile is SCNI?
SCNI has a Beta of 2.18 and 52-week volatility of 121%. It's more volatile than the S&P 500 - expect bigger swings.